Genetic and Neural Predictors of Adolescent Depression
Towards Identification of Genetic and Neural Predictors of Adolescent Depression
1 other identifier
observational
100
1 country
1
Brief Summary
This study aims to examine the relationship between mood and brain activity in adolescent girls in order to better understand the genetic and neural predictors of adolescent depression. The participants in this study will be healthy female adolescents aged 12-14 and their mothers. They will participate for a total of six months. Adolescent participants will have three study sessions at McLean Hospital, and during two of them, their mothers will also have assessments. Adolescent assessments will include interviews, questionnaires, computer tasks, and collection of a saliva sample for genetic analyses. Their second study visit will include an fMRI scan. Parent assessments will include an interview, questionnaires, and a computer task.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2012
CompletedFirst Posted
Study publicly available on registry
December 6, 2012
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedMarch 12, 2026
March 1, 2026
8.7 years
December 4, 2012
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Neurobiological Activity in Frontostriatal and Mesolimbic Regions
Baseline
Depressive Symptoms
6 months
Study Arms (4)
MDD Mothers
Adult women with a history of major depressive disorder (MDD) and a healthy adolescent daughter between the ages of 12-14
Healthy Control Mothers
Adult women with no history of psychopathology and an adolescent daughter between the ages of 12-14
High Risk Female Adolescents
Healthy female adolescents aged 12-14 with a mother in the MDD Mothers cohort
Healthy Female Adolescents
Healthy female adolescents aged 12-14 with a mother in the Healthy Control Mothers cohort.
Eligibility Criteria
This study will include two adult and two adolescent cohorts. The adult cohort includes two different groups of mothers: (a) MDD Mothers: Mothers with current or past major depressive disorder and (b) Healthy Control Mothers: Mothers with no history of psychopathology. The female adolescent cohorts are as follows: (c) High Risk Female Adolescents: Healthy female adolescents aged 12-14 with a mother reporting past or current MDD, (d) Healthy Female Adolescents: Healthy female adolescents aged 12-14 with a mother reporting no history of psychopathology.
You may qualify if:
- Current or past Major Depressive Disorder
- English as first language or English fluency
You may not qualify if:
- No history of psychopathology
- English as first language or English fluency
- Adolescent Cohort
- Female
- Ages 12-14
- English as first language or English fluency
- Right handed
- Past or present diagnosis of Major Depressive Disorder
- Past or present diagnosis of any anxiety disorder
- Past or present diagnosis of Bipolar Disorder
- Past or present diagnosis of ADHD
- Presence of medical or neurological illness (head injury, loss of consciousness greater than 5 minutes, seizure)
- Current use of psychotropic medication
- Presence of any contraindication for MRI:
- Cardiac pacemakers
- +17 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mclean Hospitallead
- The Klingenstein Third Generation Foundationcollaborator
- The Dana Foundationcollaborator
Study Sites (1)
McLean Hospital
Belmont, Massachusetts, 02478, United States
Biospecimen
Adolescent participants will provide a saliva sample for DNA analysis.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randy P. Auerbach, PhD
Mclean Hospital
- PRINCIPAL INVESTIGATOR
Diego A. Pizzagalli, PhD
Mclean Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
December 4, 2012
First Posted
December 6, 2012
Study Start
April 1, 2013
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
March 12, 2026
Record last verified: 2026-03